Please assess the completion status of the following clinical trial:

Trial Title: Nutritional and Anti-infective Interventions for Malnutrition in Pregnancy (Beleuman Welbodi)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pregnant women and consenting to study participation~* Fundal height not greater than 32 cm~* Mid-upper arm circumference ≤23 cm~* Planning to reside in the study area during pregnancy and 6 months post partum~* Attending 1 of the 40 antenatal clinic sites~Exclusion Criteria:~* \< 16 years of age without adult willing to consent~* Known pregnancy complications such as gestational diabetes, pre-eclampsia, hypertension

- Gender: FEMALE
- Minimum Age: 14 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ready-to-use supplementary food + anti-infective bundle (Type: EXPERIMENTAL): The women randomized to this arm will receive a ready-to-use-supplementary food (RUSF) designed specifically for pregnancy. The RUSF will provide a total of 520 kcal, 18 g protein, and 200% of recommended daily allowance (RDA) for most micronutrients during pregnancy. The supplement is also optimized to provide excellent protein quality and optimal polyunsaturated fatty acid composition. These women will receive 5 anti-infective interventions: 1) insecticide-treated mosquito net, 2) monthly intermittent preventive treatment of malaria during pregnancy (IPTp) 3) azithromycin at the second and third trimester 4) albendazole given in second trimester, and 5) bacterial vaginosis testing and treatment at enrollment and again at weeks 28-34
- Corn-soy-blend (Type: ACTIVE_COMPARATOR): The women randomized to this arm will receive the standard of care for Sierra Leone. The treatment provided to women in this group includes 3.5 kg super cereal with 350 g vegetable oil every two weeks. This provides 250 mg portion/day of the super cereal and 25g oil/day for the mother. Women will receive the food for the duration of their pregnancy. These women will receive the current recommendations of the government of Sierra Leone, which includes standard intermittent preventive treatment of malaria during pregnancy (IPTp) of 2 doses of sulfadoxine/ pyrimethamine, iron and folic acid supplement with a goal of 90 pills/pregnancy, an insecticide-treated mosquito net, and albendazole for deworming in the second trimester.

Based on this trial design, predict the completion outcome and termination type (if applicable).